Specificity studies on the heparin lyases from Flavobacterium heparinum.
about
Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and speciesStructural basis of heparan sulfate-specific degradation by heparinase IIIConformational flexibility of PL12 family heparinases: structure and substrate specificity of heparinase III from Bacteroides thetaiotaomicron (BT4657)Capillary electrophoresis for the analysis of glycosaminoglycans and glycosaminoglycan-derived oligosaccharides.Effects of sulfate position on heparin octasaccharide binding to CCL2 examined by tandem mass spectrometry.CCR2 chemokines bind selectively to acetylated heparan sulfate octasaccharides.Interaction of E2 glycoprotein with heparan sulfate is crucial for cellular infection of Sindbis virus.Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometryAnalysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry.Bottom-up low molecular weight heparin analysis using liquid chromatography-Fourier transform mass spectrometry for extensive characterizationHighly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractionsNot all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors.Amino acid substitutions in the E2 glycoprotein of Sindbis-like virus XJ-160 confer the ability to undergo heparan sulfate-dependent infection of mouse embryonic fibroblasts.Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages.Crystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product.Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparinCharacterizing the microstructure of heparin and heparan sulfate using N-sulfoglucosamine 1H and 15N NMR chemical shift analysisComparative assessment of the effects of gender-specific heparan sulfates on mesenchymal stem cellsHeparin-protein interactions.The Responses of Hyperglycemic Dividing Mesangial Cells to Heparin Are Mediated by the Non-reducing Terminal Trisaccharide.Bioengineered heparins and heparan sulfates.Filoviruses utilize glycosaminoglycans for their attachment to target cells.Natural variation in the heparan sulfate binding domain of the eastern equine encephalitis virus E2 glycoprotein alters interactions with cell surfaces and virulence in miceDifferentiation of 3-O-sulfated heparin disaccharide isomers: identification of structural aspects of the heparin CCL2 binding motif.Fluorescent-tagged heparan sulfate precursor oligosaccharides to probe the enzymatic action of heparitinase I.Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins.Microbial heparin/heparan sulphate lyases: potential and applications.Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms.Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [(1)H,(15)N] HSQC NMR.Exploring bacterial heparinase II activities with defined substrates.Profiling sulfation/epimerization pattern of full-length heparan sulfate by NMR following cell culture 13C-glucose metabolic labeling.Compositional profiling of heparin/heparan sulfate using mass spectrometry: assay for specificity of a novel extracellular human endosulfatase.Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro.Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites.'Immunosequencing' of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)₃ motif, recognized by antibody NS4F5, is located towards the non-reducing end.Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants.Coagulation factor IX mediates serotype-specific binding of species A adenoviruses to host cells.Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor.Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.Porcine epidemic diarrhea virus uses cell-surface heparan sulfate as an attachment factor.
P2860
Q24530061-FF5F920E-A7E2-4B8C-8872-1F86B3889423Q27673616-FEFBA0BC-DA02-417C-BE4B-0D0F67E33A8EQ27728055-859973A6-3056-4168-97D6-249A698A1A22Q30816655-FE9DF37D-3D47-467C-8C77-1246ED17ABB8Q33245170-BBCAF615-F198-4DF5-A678-62A945258848Q33289106-076929F6-919A-4A64-844E-E14EE1CBDA11Q33542995-0F105004-B32E-4A13-9D35-5EE9CE299F17Q33546538-19829F4D-B8DE-44B5-AE09-FA6C5CD4F061Q33648333-7214A55C-D23D-40C9-BDA1-004577E66938Q33847730-E350ADD5-D89D-4CCE-AD12-68ACB80CDFFDQ33864454-11F2D39B-057C-4618-96BC-B6BD4AAC2952Q34114308-B202F51D-39FD-4B7A-9BDD-267CA937EBC0Q34148988-C49B15FA-6BC8-42C1-8C0D-22C3FCA9F1A4Q34390331-8147001F-55C5-48B3-B95C-A695E7BC4EB3Q34505592-8FAB6BD8-AD5A-4B88-84BF-E46A8510B4C0Q34507805-62D3CA7F-EBC4-48D0-9AE9-584A92407AB9Q34512911-EFF00B58-7690-4AF3-91CC-CAB456A644C4Q34978967-0404CAF1-B395-4F08-9D8B-BB2890DC3613Q35030190-FFDBA000-7ADF-4417-A775-B573DD9AD711Q36323528-80DB0767-43CF-4DE8-A58D-5C3AC33C2369Q36578686-4B3ED8C0-DE5C-4FBC-8884-73A9961B1E6BQ36667804-8DD00D23-EFF5-410A-BE5D-FBDD89C7ACAEQ37036808-66973885-D7E5-42A8-9B97-8879EE56A1F0Q37379770-1CB163ED-FD41-48FD-945E-D2581657AA44Q37469129-B6CDF2DC-6B78-4F99-93A5-39FD41B13F5DQ37499263-8D3C36B3-5AE3-4F31-BE6E-C5D16FD923F1Q37990767-DA531E57-3EF9-4E4F-A2FB-ABA2DB6269C9Q38293475-00311B07-3DCD-4FBF-8C69-5EDCCF2D36C9Q38294362-CF4171D7-9FC8-4675-8C95-4FDAEB44295CQ38299516-F606A1D5-8720-4548-8DD2-C6120A2740E9Q38303432-F163563F-794B-48F0-9C8B-56F4A2471718Q38327693-39613B73-B296-44B7-9163-F3479CCC2ACCQ38334591-C57858D2-BB27-4D54-9DD3-C0D9F4AF0829Q38350614-3A2433C4-5A88-41FE-BBA8-ACDC952E03C1Q38995855-781EE1D1-891F-43DB-B0FC-4024309C4538Q39070810-FC223188-2B7E-4D67-9F22-546804D5A462Q39462577-8ACDE281-E302-463A-9F4C-6D250EFA435FQ39580237-F313227C-7E00-4BC3-A291-A2393634CFF7Q39799215-49298D92-6EE6-4FEC-AEFC-B3A6B388FC69Q41037036-DD62B461-5F14-41EF-9B29-8BE3022CA6C9
P2860
Specificity studies on the heparin lyases from Flavobacterium heparinum.
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Specificity studies on the heparin lyases from Flavobacterium heparinum.
@ast
Specificity studies on the heparin lyases from Flavobacterium heparinum.
@en
Specificity studies on the heparin lyases from Flavobacterium heparinum.
@nl
type
label
Specificity studies on the heparin lyases from Flavobacterium heparinum.
@ast
Specificity studies on the heparin lyases from Flavobacterium heparinum.
@en
Specificity studies on the heparin lyases from Flavobacterium heparinum.
@nl
prefLabel
Specificity studies on the heparin lyases from Flavobacterium heparinum.
@ast
Specificity studies on the heparin lyases from Flavobacterium heparinum.
@en
Specificity studies on the heparin lyases from Flavobacterium heparinum.
@nl
P356
P1433
P1476
Specificity studies on the heparin lyases from Flavobacterium heparinum.
@en
P2093
P304
P356
10.1021/BI00083A012
P407
P577
1993-08-01T00:00:00Z